↓ Skip to main content

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

Overview of attention for article published in Advances in Therapy, September 2014
Altmetric Badge

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials
Published in
Advances in Therapy, September 2014
DOI 10.1007/s12325-014-0155-3
Pubmed ID
Authors

Eugene B. McLaurin, Nicholas P. Marsico, Stacey L. Ackerman, Joseph B. Ciolino, Julia M. Williams, Linda Villanueva, David A. Hollander

Abstract

The efficacy and safety of the once-daily topical ophthalmic solutions, alcaftadine 0.25% and olopatadine 0.2%, in preventing ocular itching associated with allergic conjunctivitis were evaluated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 18%
Other 3 14%
Student > Bachelor 2 9%
Student > Doctoral Student 2 9%
Student > Ph. D. Student 2 9%
Other 1 5%
Unknown 8 36%
Readers by discipline Count As %
Medicine and Dentistry 7 32%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Nursing and Health Professions 1 5%
Immunology and Microbiology 1 5%
Agricultural and Biological Sciences 1 5%
Other 2 9%
Unknown 8 36%